IFNA is released by almost all cell types and a few of its family members, specifically human IFNA2a and IFN2b, are currently approved for treatment of a range of viral diseases including hepatitis B and C, condylomata acuminate (genital warts), and AIDS-related Kaposi sarcoma [15]. This evidence concerns the gene IFNA2 and viral load.